July 23, 2024CorporateMicroVention Announces Release of CLinical EValuation of WEB™ 17 Device in Intracranial Aneurysms (CLEVER): One Year Effectiveness Results for Ruptured and Unruptured AneurysmsMicroVention is Also Celebrating the Five-Year Anniversary of its WEB™ Aneurysm Embolization System with more than 10,000 Units Sold in the United States
July 11, 2024FinancialNotice Regarding Disposal of Treasury Shares as Restricted Stock Remuneration (PDF 142.31 KB)
July 11, 2024FinancialNotice Concerning the Issuance of Stock Options (Share Warrants) (PDF 114.67 KB)
Stories Our Technologies Introducing the Terumo Group’s R&D and production engineering initiatives. #12 Personalized Treatment of Liver Cancer Using Microscopic Radioactive Beads #11 Keeping Hope Alive: The Story of the Terumo Implantable Left Ventricular Assist System #10 "Hybrid" Graft Technologies to Support the Evolution of Aortic Treatment #09 Delivering Efficiency and Quality to Cell Therapy Manufacturing #08 Improving Interventional Treatment Quality Pursuing Intravascular Imaging Technology #07 ICT Healthcare Evolution and the State of Pharmaceutical Infusion Systems #06 Terumo Bay Area Innovation Lab A place to create new value #05 Creating Core Technologies to Contribute into the Future #04 Integrating Technologies to Give Diabetes Patients Lifestyle Freedom #03 Technology that Meets Patients’ Medication Needs with Safety and Certainty #02 Continuously Innovating First-in-class Technology to Support Cardiovascular Surgery #01 Intervention through the Wrist Thirty Years of Evolution; More to Come